ANVISA bans and removes all branded products from stores

ANVISA has just issued a strict ban on all products from this brand and this is the situation

And the Anvisa (National Health Surveillance Agency) just issued a ban on a well-known brand in the world Markets Which you’ve definitely heard about already.

We’re talking about branding connectOne the shop The natural products giant that calls itself “The largest cannabis ecosystem in Latin America”

According to the portal power 360, As published in The official diary of the federationAt the end of September, specifically on September 28, 2023, everyone Its medical cannabis products were Probbed To be sold in stores, as well as published and consumed.

Announcement of the decision It was published in Give (The official daily of the Union) Signed by the Director General of Health Inspection, Marcos Aurelio Miranda de Araujo.

the reasons:

Billions of dollars in debt, central bank intervention and bankruptcy: the sad end of traditional banking and the announcement in JN

Selling to a competitor and closing programmes: the sad end of a Brazilian TV station after years of broadcasting

Excellent news from Bolsa Família arrives on Sunday (15): the updated payment schedule drops as a gift

According to what was published by the supervisory authority, the suspension was due to:

“WConsent to advertise cannabis products on the Site [da Cannect]Which are described as products without registration or license with Anvisa.”.

This measure is preventive in nature, and is used when the agency assesses that there is an imminent risk to the health of residents, without prior appearance by the other interested party.

The decision also stipulates the following: “Specific inspection procedures apply to all websites, social media profiles and other communications under the responsibility of Cannect and its partners.”.

Still according to Power 360While searching for Cannect, the company issued an official statement about what happened, claiming that it follows all of the company’s decisions. Anvisa It is guided by technical and scientific precision.

The company also states that its products are sold under the appropriate controlled prescription and undergo the stringent ANVISA approval process.

Provide a controlled prescription “Undergoes Anvisa’s stringent approval process.”.

See the company’s full statement below:

“With regard to the Anvisa memorandum published in the 29/09/2023 edition of the DOU, we reiterate that our procedures follow all decisions of the regulatory agency and are guided by technical and scientific rigor, described in the literature, and supported by a medical committee composed of renowned experts with expertise in their respective fields.

The medical cannabis based products in our portfolio are supplied based on the submission of a private, controlled prescription (Blue Prescription Type B) and submission to Anvisa’s stringent approval process.

We also recognize that Anvisa plays a vital role in the protection and safety of the population’s health, and we reaffirm our commitment to the sector regulation in place in our country..

How is the brand positioned now?

According to my findings Focus TVwebsite of connect is active, but its products, at the moment, can only be purchased there.

It is worth noting that on its official website it is possible to see that in fact its products can only be sold by prescription. Anyone who chooses the “I don’t have a prescription” option is automatically directed to A Schedule appointments.

As you can see in the pictures below: